Akèy › Myelom miltip k ap boukante › Utah
Etid klinik pou Myelom miltip k ap boukante nan Utah
3 etid pou Myelom miltip k ap boukante ap chèche patisipan nan sit nan Utah.
Vil nan Utah
Tèks ofisyèl etid la (Anglè)
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT03937635Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06212323Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- University of Utah, Huntsman Cancer Hospital, Salt Lake City
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT06365060Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.